Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teniposide, Cisplatin and Serplulimab vs Etoposide, Cisplatin and Serplulimab in Extensive Stage Small Cell Lung Cancer
NCT07583511Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2024
- Primary completion
- May 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of teniposide in small cell lung cancer (SCLC), sponsored by Sun Yat-sen University. Started Feb 2024; status: recruiting.
02
Drugs
teniposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT07583511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07583511.